Top Story

2026 06 08 Tattoos Homepage Image
Home
Tattoo pigments can have significant impact on imaging
Tattoos can appear as shadows or artifacts on an x-ray, causing confusion during interpretation. Research presented at the U.K. Imaging and Oncology congress has provided new data on which tattoo inks have the greatest impact.
Featured
Biparametric prostate MRI identified clinically significant Gleason 3+4 prostate cancer using T2-weighted imaging, diffusion-weighted imaging, and ADC mapping alone.
MRI
SERAM 2026: Biparametric MRI cuts time and costs in prostate cancer imaging
An AI system highlights multiple abnormalities on a chest radiograph, including a pulmonary nodule (nódulo pulmonar), pleural effusion (derrame pleural), and alveolar syndrome/consolidation (síndrome alveolar).
Digital X-Ray
SERAM 2026: AI chest triage cuts referrals without raising CT use
Latest News
Am 2020 06 26 16 29 2945 Cancer Lung 400
AI detects lung cancer nodules well but shows low specificity
June 4, 2026
Preablation, postablation, and recurrence multiparametric MRI scans depict a 63-year-old man treated with transperineal focal laser ablation (TPLA) for localized prostate cancer. Clinical parameters included an initial prostate-specific antigen (PSA) level of 7.2 ng/mL, a Prostate Imaging Reporting and Data System (PI-RADS) grade 4 lesion (red circles) in the right apical peripheral zone, and a maximum tumor length of 5 mm. MRI-guided targeted biopsy confirmed a Gleason score 3+4 prostate cancer tumor. (A) Pre-ablation axial T2-weighted MRI scan and apparent diffusion coefficient (ADC) image shows the apical PI-RADS 4 lesion (circles). (B) Six-month post-ablation axial T2-weighted MRI scan and ADC image show cystic necrosis (arrows). There was no evidence of recurrence; the PSA level was 1.5 ng/mL. (C) One-year after ablation, the patient’s PSA level had increased to 4.3 ng/mL. Axial T2-weighted MRI scan and the ADC image shows a recurrent lesion (blue circles) in the right apical peripheral zone adjacent to the ablation scar. Targeted biopsy confirmed Gleason score 3+4 prostate cancer, which was classified as in-field recurrence of clinically significant prostate cancer and subsequently re-treated with TPLA. In summary, serial multiplanar MRI demonstrates treatment response after TPLA with post-ablation necrosis, followed by MRI-detected IFR confirmed with biopsy at 12-month follow-up. Multiparametric MRI was performed with a 3.0-T MRI scanner (Skyra; Siemens Healthineers) using T2-weighted, diffusion-weighted, and ADC sequences, with gadobenate dimeglumine contrast material administration (Bracco Diagnostics).
Image-guided focal laser ablation effective for prostate cancer
June 3, 2026
AI for CT & PET/CT Imaging
Sponsored
AI for CT & PET/CT Imaging
June 4, 2026
Grad-CAM heatmaps showing the AI model's areas of attention overlaid on standard mammography views, as displayed to radiologists during the XAI-assisted reading sessions.
AI can mislead radiologists -- and make the error more persuasive
June 2, 2026
Cases of the Week
Check out our Cases of the Week!
34-year-old man with anomaly on cardiac CT
A 34-year-old man presented for a contrast-enhanced cardiac CT.
39-year-old man with orbital proptosis, possible orbital mass
68-year-old woman with elevated calcium, parathyroid hormone
View All Cases
2026 06 08 Tattoos Homepage Image
Home
Tattoo pigments can have significant impact on imaging
MRI
SERAM 2026: Biparametric MRI cuts time and costs in prostate cancer imaging
Digital X-Ray
SERAM 2026: AI chest triage cuts referrals without raising CT use
CT
AI detects lung cancer nodules well but shows low specificity
Interventional
Image-guided focal laser ablation effective for prostate cancer
Grad-CAM heatmaps showing the AI model's areas of attention overlaid on standard mammography views, as displayed to radiologists during the XAI-assisted reading sessions.
AI
AI can mislead radiologists -- and make the error more persuasive
AI
SERAM 2026: AI-assisted triage in deep neck infections
MRI
AI diagnostic aid helps novice MRI readers, but experts not so much
RöKo 2026
RöKo 2026: Nikolaou on AI policy, data gaps, and a prostate cancer paradox
Womens Imaging
AI model predicts 10-year breast cancer risk
Waiting Room Seniors Masks 400
Health Equity
1.92M patients waiting for NHS diagnostic tests in England
Industry News
SCCT, SCAI publish fractional flow reserve in CCTA guideline
Clinical News
Royal Philips, WellSpan Health announce seven-year imaging alliance
Industry News
QT Imaging secures clearance for CT scanner in Saudi Arabia
Nuclear Medicine
Curium to invest €32M in French radiopharmaceutical facility
More from AuntMinnieEurope
1.92M patients waiting for NHS diagnostic tests in England
By AuntMinnieEurope.com staff writers
The waiting list has grown by 500,000 since 2022, according to health technology firm Magentus.
June 8, 2026
Waiting Room Seniors Masks 400
SCCT, SCAI publish fractional flow reserve in CCTA guideline
By AuntMinnie.com staff writers
The document was crafted by a team from King's College London in the U.K.
June 8, 2026
Heart Damage
Royal Philips, WellSpan Health announce seven-year imaging alliance
By AuntMinnie.com staff writers
Royal Philips and WellSpan Health have entered a strategic alliance to bring new imaging products to WellSpan's health system.
June 4, 2026
WellSpan New York Hospital
QT Imaging secures clearance for CT scanner in Saudi Arabia
By AuntMinnie.com staff writers
The company has now secured regulatory clearance in both Saudi Arabia and the United Arab Emirates.
June 3, 2026
Clearance
Curium to invest €32M in French radiopharmaceutical facility
By AuntMinnieEurope.com staff writers
The investment will go toward development of a new production line for lutetium-177 PSMA-I&T, a targeted radioligand therapy.
June 1, 2026
France Flag Button 400
4DMedical acquires contextflow to expand into European lung imaging
By AuntMinnie.com staff writers
4DMedical is entering the European market with its acquisition of contextflow.
June 1, 2026
Lung Technology Medicine 400
SERAM 2026: AI-assisted triage in deep neck infections
By Claudia Tschabuschnig
AI models trained on CT and laboratory data showed promise for predicting ICU admission, surgery and tracheostomy in patients with deep neck infections.
June 1, 2026
Valencia became the center of Spanish radiology from 20–23 May as the city hosted SERAM 2026, one of the country's largest medical imaging meetings.
SNMMI: SPECT/CT tracer shows promise in interstitial lung disease
By Will Morton
Differentiating between fibrotic scarring and inflammation stages of disease is critical so that physicians can determine what treatment is best for the patient.
May 31, 2026
Sample images from each participant group: A: CT only; B: fused Tc-99m maraciclatide SPECT/CT.
SNMMI: Machine-learning model predicts RPT dose
By Will Morton
Dosimetry plays a central role in optimizing lutetium-177 (Lu-177) PSMA therapy, yet calculating it currently depends on post-therapy imaging.
May 30, 2026
Snmmi Thumb
Eye movement abnormalities flag brain health risk in ex-racing drivers
By Kate Madden Yee
A case series of 12 male retired professional motorsport drivers showed a high prevalence of mild neurological abnormalities.
May 29, 2026
Racecare Thumb
Video from RöKo 2026: Beckelmann on workforce reform, leadership, and radiology supply
By Claudia Tschabuschnig
Bettina Beckelmann discussed workforce reform, leadership, and radiology supply in a video interview at RöKo 2026.
May 29, 2026
Bettina Beckelmann, Managing Director of Beckelmann GmbH, a Dortmund-based family-owned radiology supplies company.
MMA embolization cuts recurrence risk in chronic subdural hematoma, trials show
By Claudia Tschabuschnig
Adding embolization to subdural hematoma surgery reduces recurrence rates, five randomized trials show.
May 28, 2026
71-year-old patient with headaches and unsteady gait. Coronal MRI before embolization demonstrating a chronic subdural hematoma (cSDH).